SC
PLSE icon

Steven Cohen’s Pulse Biosciences PLSE Stock Holding History

Steven Cohen’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95M Buy
+106,457
New +$2.51M ﹤0.01% 2142

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Steven Cohen's PLSE Position: Q2 2026 in Review

Steven Cohen opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 106,457 shares worth $2.95M. The stake represents ﹤0.01% of the portfolio and ranks #2142 among its holdings.

105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Steven Cohen held 106,457 shares of Pulse Biosciences worth $2.95M as of Q2 2026.
  • Pulse Biosciences was a new Steven Cohen position in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2142 holding.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.